Skip to content

Mescaline: all studies

Page 51 of 98: studies 501 to 510 of 977, newest first. Back to the mescaline overview

Research

Lysergic Acid Diethylamide (LSD-25) as a Facilitating Agent in Psychotherapy

Archives of General Psychiatry March 1, 1960 Arthur L. Chandler 77 citations

Our use of drug-facilitated psychotherapy has been to aid repressed material to become conscious and to increase insight. Any method or tool which facilitates these processes has the possibility of being a valuable psychotherapeutic tool. Certain drugs on which we have done research, such as mescaline, ALD-52, ibogaine, psilocybin, Ditran (N-ethyl-3-piperidyl cyclopentylphenyl glycolate HC1),...

Influence of Lysergic Acid Diethylamide (LSD-25) on Subjective Time

Archives of General Psychiatry November 1, 1959 H. Aronson 32 citations

Introduction Various reports1,14have shown that the subjective sense of time can be considerably altered through changes in the external circumstances under which the judgment is made. Somewhat less is known of the influence of the subject’s physical state on his ability to estimate time. This lack may be at least partially due to the fact that most conditions, such as fever or delirium, which...

The Secondary Conditioned Response of Rats and the Effects of Some Psychopharmacological Agents

Journal of Pharmacy and Pharmacology September 1, 1959 G Maffii 58 citations

Abstract The secondary conditioned response has been studied in rats in an experimental avoidance situation. The activity of seventeen drugs has been tested upon the secondary conditioned response developed on a stable basis after an appropriate period of training. Chlorpromazine, promazine, reserpine and morphine block the secondary avoidance conditioned response as well as the usual avoidance...

DOI: 10.1111/j.2042-7158.1959.tb12535.x (opens in new tab) Mescaline Avoidance response Chlorpromazine Iproniazid +9

Study of a New Schizophrenomimetic Drug—Sernyl

Archives of Neurology And Psychiatry March 1, 1959 Elliot D. Luby 920 citations

Introduction The production of model psychoses has been employed as a technique for testing hypotheses relevant to the causes, correlates, and treatment of schizophrenia since 1921, when De Jong demonstrated experimental catatonia by giving bulbocapnine to animals.5This method of study has received considerable impetus with the discovery of the hallucinogenic properties of lysergic acid...

A Clinical and Metabolic Study of Acute Intoxication with Cannabis Sativa and its Role in the Model Psychoses

Journal of Mental Science October 1, 1958 Frances R. Ames 184 citations

This paper describes an inquiry into the effects of giving oral doses of the narcotic drug variously known as hashish, marihuana and, in South Africa, dagga. The drug is a preparation from the plant Cannabis sativa whose narcotic effect has been known for centuries. The writer's interest in it was inspired by the work in recent years on the mental disturbances produced by the active principles...

Synergism of Amines and Antagonism of Reserpine to Morphine Analgesia

Experimental Biology and Medicine 1958 E. B. Sigg, G. Caprio, J. A. Schneider 78 citations

(1) Reserpine antagonizes the analgesia in mice induced by morphine, meperidine and codeine. (2) Five-hydroxytryptophane, 5-hydroxytryptamine, tryptamine, amphetamine, mescaline and epinephrine prolong and enhance morphine analgesia whereas iproniazid and choline-p-tolyl-ether fail to do so. (3) Possible mechanisms involved in the synergistic action of amines and the antagonistic action of...

THE PRESERVATION OF SUBSTANCE P BY LYSERGIC ACID DIETHYLAMIDE

British Journal of Pharmacology and Chemotherapy September 1, 1957 William A. Krivoy 23 citations

Lysergic acid diethylamide (LSD) potentiated the response of guinea‐pig ileum to substance P but not to histamine. It also inhibited the disappearance of substance P when incubated with guinea‐pig brain extract but not when incubated with chymotrypsin. Eserine, morphine, mescaline, chlorpromazine, ergometrine, strychnine and 2 bromo‐LSD did not have this effect. Oxytocin was not destroyed by...

PSYCHOTOMIMETICS, CLINICAL AND THEORETICAL CONSIDERATIONS: HARMINE, WIN-2299 AND NALLINE

American Journal of Psychiatry April 1, 1957 Harry H. Pennes, Paul H. Hoch 89 citations

Harmine, Win-2299, and Nalline in single dosage produce many new mental effects in schizophrenics grossly similar to those elicited by mescaline and LSD. Many of the same effects are reported in normals after harmine and Nalline (other workers). unlike mescaline and LSD at usual dosage levels, the present psychotomimetics regularly produce drowsiness and sleep along with the aberrant mental...

Model Psychoses Induced by LSD-25 in Normals

A M A Archives of Neurology & Psychiatry June 1, 1956 Nicholas A. Bercel 35 citations

INTRODUCTION Experimental psychosis has a long history. It might have started with the administration of Cannabis indica boiling in wine to the ancient Hun warriors, resulting in mental obfuscation, as they were prepared for surgery because of wounds sustained in battle. Scientific experimental psychiatry began toward the end of the last century, in the Kraepelinian era—when the organic theory...

DOI: 10.1001/archneurpsyc.1956.02330240026003 (opens in new tab) Mescaline Cannabis Methaqualone Schizophrenia object-oriented programming +6

Some Effects of Bufotenine and Lysergic Acid Diethylamide on the Monkey

Archives of Neurology And Psychiatry 1956 Edward V. Evarts 52 citations

INTRODUCTION Bufotenine (5 -hydroxy -3 -[2- dimethyl-aminoethyl]-indole) is the N-dimethyl derivative of the vasoconstrictor substance serotonin (5-hydroxytryptamine). It was first synthesized by Wieland in 1934. Raymond-Hamet found that intravenous injection of bufotenine caused transient elevation of blood pressure and apnea, followed by tachypnea, in anesthetized dogs.* To date, however,...